FindTrial
Sign In

Comparison of marma therapy and Hridya amrit vati in high blood pressure

A multi-centre study : comparison of marma therapy and Hridya Amrit Vati in the treatment of stage 1 hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025316
Enrollment
30
Registered
2020-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Marma therapy along with life style modification: Marma therapy thrice a day will be done along with Life style modification in stage one hypertensive patients Control Intervention1: Hr

Sponsors

Uttarakhand ayurved University Rishikul campus haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects will be enrolled with stage 1 hypertension (130-139/80-89) Hypertensive patients who are drug-naive will be enrolled for the study Normal LV function

Exclusion criteria

Exclusion criteria: Hypertensive patients with B.P greater or equal to 140 / 90 mmHg LVEF CKD , Serum creatinine > 1.7

Design outcomes

Primary

MeasureTime frame
lowering in B.P from 140/90 mmhg to the normal ( Acc to the ACC and AHA )Timepoint: 6 months—

Secondary

MeasureTime frame
not anyTimepoint: not any—

Countries

India

Contacts

Public ContactDr Nikita khetwal

uttarakhand Ayurved University ,Harrawala ,Dehradoon

mrityunjaymission@gmail.com9897523499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026